Clinical Trial Update: Basket Trial in Solid Tumors Harboring a Fusion of FGFR1, FGFR2 or FGFR3- (FUZE Clinical Trial) [Phase 2]

View source ↗

Summary

A Phase 2 basket trial evaluating FGFR1/2/3 fusions in solid tumors was terminated; results posted in 2024.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumor

Snippet

Sponsor: Debiopharm International SA | Conditions: Solid Tumor | Phase 2 | Status: TERMINATED | Results posted: 2024-02-07